SCHEMBL7974033

SCHEMBL7974033

CN(CCCc1nc2ncn(Cc3ccccc3)c2c(=O)[nH]1)C(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 2/20 0.44
CCNE2 O96020 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
MCL1 Q07820 1/20 0.36
GAA P10253 1/20 0.36
HCAR2 Q8TDS4 4/20 0.36
PARN O95453 1/20 0.36
CNOT7 Q9UIV1 1/20 0.36
PNP P00491 1/20 0.36
MEN1 O00255 1/20 0.36
BRD4 O60885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988916 0.95 HPGD (0.50) HPGDSMN1; SMN2ALDH1A1KMT2ACCNE2
SCHEMBL7985463 0.89 HPGD (0.52) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7974030 0.86 CNOT7 (0.42) HPGDSMN1; SMN2ALDH1A1CCNE2CCNE1
SCHEMBL7985298 0.83 ALDH1A1 (0.52) HPGDSMN1; SMN2ALDH1A1KMT2APARN
SCHEMBL7974183 0.83 HPGD (0.51) HPGDSMN1; SMN2ALDH1A1KMT2AMCL1
SCHEMBL7985320 0.82 LMNA (0.47) HPGDSMN1; SMN2ALDH1A1HTR2CSLC6A4
SCHEMBL7974025 0.82 HTR2C (0.39) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7991611 0.82 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1KMT2AHTR2C
SCHEMBL7987946 0.81 HPGD (0.42) HPGDSMN1; SMN2ALDH1A1KMT2ACCNE2
SCHEMBL7991666 0.81 SMN1; SMN2 (0.53) HPGDSMN1; SMN2ALDH1A1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed